Brief: atai Life Sciences And Beckley Psytech To Combine Creating A Global Leader In Psychedelic Mental Health Therapies

AtaiBeckley

02/06/2025 13:09

June 2 (Reuters) - ATAI Life Sciences NV 9VC.DE:

ATAI LIFE SCIENCES AND BECKLEY PSYTECH TO COMBINE CREATING A GLOBAL LEADER IN PSYCHEDELIC MENTAL HEALTH THERAPIES

ATAI LIFE SCIENCES NV - COMBINED COMPANY TO OPERATE AS ATAI BECKLEY

ATAI LIFE SCIENCES NV - DEAL  VALUES BECKLEY AT ABOUT $390 MILLION

ATAI LIFE SCIENCES NV - PHASE 2B STUDY DATA FOR BPL-003 EXPECTED MID-2025

ATAI LIFE SCIENCES NV - BECKLEY ALSO INTENDS TO DISTRIBUTE ELEUSIS HOLDINGS LIMITED AND ITS SUBSIDIARIES

ATAI LIFE SCIENCES NV - CONCURRENT $30 MILLION PRIVATE PLACEMENT BY FERRING VENTURES AND ADAGE CAPITAL

Source text: ID:nGNX1S1Dxs

Further company coverage: 9VC.DE

 ((Reuters.Briefs@thomsonreuters.com;))